img

Global Interleukin 17A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Interleukin 17A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Interleukin 17A report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Interleukin 17A market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Pain and Liver Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Interleukin 17A industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Interleukin 17A key manufacturers include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. AbbVie Inc, Abeome Corporation, Affibody AB are top 3 players and held % sales share in total in 2022.
Interleukin 17A can be divided into ABY-035, CNTO-6785, DLX-2882 and Others, etc. ABY-035 is the mainstream product in the market, accounting for % sales share globally in 2022.
Interleukin 17A is widely used in various fields, such as Chronic Pain, Liver Cancer, Kidney Cancer and Others, etc. Chronic Pain provides greatest supports to the Interleukin 17A industry development. In 2022, global % sales of Interleukin 17A went into Chronic Pain filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Interleukin 17A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Segment by Type
ABY-035
CNTO-6785
DLX-2882
Others

Segment by Application


Chronic Pain
Liver Cancer
Kidney Cancer
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Interleukin 17A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Interleukin 17A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Interleukin 17A industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Interleukin 17A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Interleukin 17A introduction, etc. Interleukin 17A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Interleukin 17A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Interleukin 17A Market Overview
1.1 Interleukin 17A Product Overview
1.2 Interleukin 17A Market Segment by Type
1.2.1 ABY-035
1.2.2 CNTO-6785
1.2.3 DLX-2882
1.2.4 Others
1.3 Global Interleukin 17A Market Size by Type
1.3.1 Global Interleukin 17A Market Size Overview by Type (2018-2034)
1.3.2 Global Interleukin 17A Historic Market Size Review by Type (2018-2024)
1.3.3 Global Interleukin 17A Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Interleukin 17A Sales Breakdown by Type (2018-2024)
1.4.2 Europe Interleukin 17A Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Interleukin 17A Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Interleukin 17A Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Interleukin 17A Sales Breakdown by Type (2018-2024)
2 Global Interleukin 17A Market Competition by Company
2.1 Global Top Players by Interleukin 17A Sales (2018-2024)
2.2 Global Top Players by Interleukin 17A Revenue (2018-2024)
2.3 Global Top Players by Interleukin 17A Price (2018-2024)
2.4 Global Top Manufacturers Interleukin 17A Manufacturing Base Distribution, Sales Area, Product Type
2.5 Interleukin 17A Market Competitive Situation and Trends
2.5.1 Interleukin 17A Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Interleukin 17A Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interleukin 17A as of 2022)
2.7 Date of Key Manufacturers Enter into Interleukin 17A Market
2.8 Key Manufacturers Interleukin 17A Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Interleukin 17A Status and Outlook by Region
3.1 Global Interleukin 17A Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Interleukin 17A Historic Market Size by Region
3.2.1 Global Interleukin 17A Sales in Volume by Region (2018-2024)
3.2.2 Global Interleukin 17A Sales in Value by Region (2018-2024)
3.2.3 Global Interleukin 17A Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Interleukin 17A Forecasted Market Size by Region
3.3.1 Global Interleukin 17A Sales in Volume by Region (2024-2034)
3.3.2 Global Interleukin 17A Sales in Value by Region (2024-2034)
3.3.3 Global Interleukin 17A Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Interleukin 17A by Application
4.1 Interleukin 17A Market Segment by Application
4.1.1 Chronic Pain
4.1.2 Liver Cancer
4.1.3 Kidney Cancer
4.1.4 Others
4.2 Global Interleukin 17A Market Size by Application
4.2.1 Global Interleukin 17A Market Size Overview by Application (2018-2034)
4.2.2 Global Interleukin 17A Historic Market Size Review by Application (2018-2024)
4.2.3 Global Interleukin 17A Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Interleukin 17A Sales Breakdown by Application (2018-2024)
4.3.2 Europe Interleukin 17A Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Interleukin 17A Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Interleukin 17A Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Interleukin 17A Sales Breakdown by Application (2018-2024)
5 North America Interleukin 17A by Country
5.1 North America Interleukin 17A Historic Market Size by Country
5.1.1 North America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Interleukin 17A Sales in Volume by Country (2018-2024)
5.1.3 North America Interleukin 17A Sales in Value by Country (2018-2024)
5.2 North America Interleukin 17A Forecasted Market Size by Country
5.2.1 North America Interleukin 17A Sales in Volume by Country (2024-2034)
5.2.2 North America Interleukin 17A Sales in Value by Country (2024-2034)
6 Europe Interleukin 17A by Country
6.1 Europe Interleukin 17A Historic Market Size by Country
6.1.1 Europe Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Interleukin 17A Sales in Volume by Country (2018-2024)
6.1.3 Europe Interleukin 17A Sales in Value by Country (2018-2024)
6.2 Europe Interleukin 17A Forecasted Market Size by Country
6.2.1 Europe Interleukin 17A Sales in Volume by Country (2024-2034)
6.2.2 Europe Interleukin 17A Sales in Value by Country (2024-2034)
7 Asia-Pacific Interleukin 17A by Region
7.1 Asia-Pacific Interleukin 17A Historic Market Size by Region
7.1.1 Asia-Pacific Interleukin 17A Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Interleukin 17A Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Interleukin 17A Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Interleukin 17A Forecasted Market Size by Region
7.2.1 Asia-Pacific Interleukin 17A Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Interleukin 17A Sales in Value by Region (2024-2034)
8 Latin America Interleukin 17A by Country
8.1 Latin America Interleukin 17A Historic Market Size by Country
8.1.1 Latin America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Interleukin 17A Sales in Volume by Country (2018-2024)
8.1.3 Latin America Interleukin 17A Sales in Value by Country (2018-2024)
8.2 Latin America Interleukin 17A Forecasted Market Size by Country
8.2.1 Latin America Interleukin 17A Sales in Volume by Country (2024-2034)
8.2.2 Latin America Interleukin 17A Sales in Value by Country (2024-2034)
9 Middle East and Africa Interleukin 17A by Country
9.1 Middle East and Africa Interleukin 17A Historic Market Size by Country
9.1.1 Middle East and Africa Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Interleukin 17A Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Interleukin 17A Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Interleukin 17A Forecasted Market Size by Country
9.2.1 Middle East and Africa Interleukin 17A Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Interleukin 17A Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Inc Interleukin 17A Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Abeome Corporation
10.2.1 Abeome Corporation Company Information
10.2.2 Abeome Corporation Introduction and Business Overview
10.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Abeome Corporation Interleukin 17A Products Offered
10.2.5 Abeome Corporation Recent Development
10.3 Affibody AB
10.3.1 Affibody AB Company Information
10.3.2 Affibody AB Introduction and Business Overview
10.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Affibody AB Interleukin 17A Products Offered
10.3.5 Affibody AB Recent Development
10.4 Cell Medica Limited
10.4.1 Cell Medica Limited Company Information
10.4.2 Cell Medica Limited Introduction and Business Overview
10.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cell Medica Limited Interleukin 17A Products Offered
10.4.5 Cell Medica Limited Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli Lilly and Company Interleukin 17A Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Johnson & Johnson Interleukin 17A Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Merck KGaA
10.7.1 Merck KGaA Company Information
10.7.2 Merck KGaA Introduction and Business Overview
10.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck KGaA Interleukin 17A Products Offered
10.7.5 Merck KGaA Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Introduction and Business Overview
10.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis AG Interleukin 17A Products Offered
10.8.5 Novartis AG Recent Development
10.9 Orega Biotech SAS
10.9.1 Orega Biotech SAS Company Information
10.9.2 Orega Biotech SAS Introduction and Business Overview
10.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Orega Biotech SAS Interleukin 17A Products Offered
10.9.5 Orega Biotech SAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Interleukin 17A Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Interleukin 17A Industrial Chain Analysis
11.4 Interleukin 17A Market Dynamics
11.4.1 Interleukin 17A Industry Trends
11.4.2 Interleukin 17A Market Drivers
11.4.3 Interleukin 17A Market Challenges
11.4.4 Interleukin 17A Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Interleukin 17A Distributors
12.3 Interleukin 17A Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ABY-035
Table 2. Major Company of CNTO-6785
Table 3. Major Company of DLX-2882
Table 4. Major Company of Others
Table 5. Global Interleukin 17A Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Interleukin 17A Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Interleukin 17A Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Interleukin 17A Sales by Type (2018-2024) & (US& Million)
Table 9. Global Interleukin 17A Market Share in Value by Type (2018-2024)
Table 10. Global Interleukin 17A Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Interleukin 17A Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Interleukin 17A Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Interleukin 17A Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Interleukin 17A Sales Market Share in Value by Type (2024-2034)
Table 15. Global Interleukin 17A Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Interleukin 17A Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Interleukin 17A Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Interleukin 17A Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Interleukin 17A Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Interleukin 17A Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Interleukin 17A Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Interleukin 17A Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Interleukin 17A Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Interleukin 17A Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Interleukin 17A Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Interleukin 17A Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Interleukin 17A Sales Share by Company (2018-2024)
Table 28. Global Interleukin 17A Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Interleukin 17A Revenue Share by Company (2018-2024)
Table 30. Global Market Interleukin 17A Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Interleukin 17A Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Interleukin 17A Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interleukin 17A as of 2022)
Table 34. Date of Key Manufacturers Enter into Interleukin 17A Market
Table 35. Key Manufacturers Interleukin 17A Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Interleukin 17A Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Interleukin 17A Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Interleukin 17A Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Interleukin 17A Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Interleukin 17A Sales Market Share in Value by Region (2018-2024)
Table 42. Global Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Interleukin 17A Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Interleukin 17A Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Interleukin 17A Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Interleukin 17A Sales Market Share in Value by Region (2024-2034)
Table 47. Global Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Interleukin 17A Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Interleukin 17A Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Interleukin 17A Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Interleukin 17A Sales Market Share in Value by Application (2018-2024)
Table 53. Global Interleukin 17A Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Interleukin 17A Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Interleukin 17A Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Interleukin 17A Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Interleukin 17A Sales Market Share in Value by Application (2024-2034)
Table 58. Global Interleukin 17A Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Interleukin 17A Sales by Application (2018-2024) (K Pcs)
Table 60. North America Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Interleukin 17A Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Interleukin 17A Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Interleukin 17A Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Interleukin 17A Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Interleukin 17A Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Interleukin 17A Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Interleukin 17A Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Interleukin 17A Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Interleukin 17A Sales Market Share in Value by Country (2018-2024)
Table 73. North America Interleukin 17A Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Interleukin 17A Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Interleukin 17A Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Interleukin 17A Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Interleukin 17A Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Interleukin 17A Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Interleukin 17A Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Interleukin 17A Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Interleukin 17A Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Interleukin 17A Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Interleukin 17A Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Interleukin 17A Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Interleukin 17A Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Interleukin 17A Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Interleukin 17A Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Interleukin 17A Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Interleukin 17A Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Interleukin 17A Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Interleukin 17A Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Interleukin 17A Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Interleukin 17A Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Interleukin 17A Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Interleukin 17A Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Interleukin 17A Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Interleukin 17A Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Interleukin 17A Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Interleukin 17A Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Interleukin 17A Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Interleukin 17A Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Interleukin 17A Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Interleukin 17A Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Interleukin 17A Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Interleukin 17A Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Interleukin 17A Sales Market Share in Value by Country (2024-2034)
Table 109. AbbVie Inc Company Information
Table 110. AbbVie Inc Introduction and Business Overview
Table 111. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. AbbVie Inc Interleukin 17A Product
Table 113. AbbVie Inc Recent Development
Table 114. Abeome Corporation Company Information
Table 115. Abeome Corporation Introduction and Business Overview
Table 116. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Abeome Corporation Interleukin 17A Product
Table 118. Abeome Corporation Recent Development
Table 119. Affibody AB Company Information
Table 120. Affibody AB Introduction and Business Overview
Table 121. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Affibody AB Interleukin 17A Product
Table 123. Affibody AB Recent Development
Table 124. Cell Medica Limited Company Information
Table 125. Cell Medica Limited Introduction and Business Overview
Table 126. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Cell Medica Limited Interleukin 17A Product
Table 128. Cell Medica Limited Recent Development
Table 129. Eli Lilly and Company Company Information
Table 130. Eli Lilly and Company Introduction and Business Overview
Table 131. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Eli Lilly and Company Interleukin 17A Product
Table 133. Eli Lilly and Company Recent Development
Table 134. Johnson & Johnson Company Information
Table 135. Johnson & Johnson Introduction and Business Overview
Table 136. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Johnson & Johnson Interleukin 17A Product
Table 138. Johnson & Johnson Recent Development
Table 139. Merck KGaA Company Information
Table 140. Merck KGaA Introduction and Business Overview
Table 141. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Merck KGaA Interleukin 17A Product
Table 143. Merck KGaA Recent Development
Table 144. Novartis AG Company Information
Table 145. Novartis AG Introduction and Business Overview
Table 146. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Novartis AG Interleukin 17A Product
Table 148. Novartis AG Recent Development
Table 149. Orega Biotech SAS Company Information
Table 150. Orega Biotech SAS Introduction and Business Overview
Table 151. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Orega Biotech SAS Interleukin 17A Product
Table 153. Orega Biotech SAS Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Interleukin 17A Market Trends
Table 157. Interleukin 17A Market Drivers
Table 158. Interleukin 17A Market Challenges
Table 159. Interleukin 17A Market Restraints
Table 160. Interleukin 17A Distributors List
Table 161. Interleukin 17A Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin 17A Product Picture
Figure 2. Global Interleukin 17A Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Interleukin 17A Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Interleukin 17A Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ABY-035
Figure 6. Global ABY-035 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CNTO-6785
Figure 8. Global CNTO-6785 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of DLX-2882
Figure 10. Global DLX-2882 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Interleukin 17A Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Interleukin 17A Sales Market Share by Type in 2022 & 2034
Figure 15. North America Interleukin 17A Sales Market Share in Volume by Type in 2022
Figure 16. North America Interleukin 17A Sales Market Share in Value by Type in 2022
Figure 17. Europe Interleukin 17A Sales Market Share in Volume by Type in 2022
Figure 18. Europe Interleukin 17A Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Interleukin 17A Sales Market Share in Value by Type in 2022
Figure 21. Latin America Interleukin 17A Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Interleukin 17A Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Interleukin 17A Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Interleukin 17A Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Interleukin 17A Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Interleukin 17A Revenue in 2022
Figure 27. Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Chronic Pain
Figure 29. Global Chronic Pain Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Liver Cancer
Figure 31. Global Liver Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Kidney Cancer
Figure 33. Global Kidney Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Interleukin 17A Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Interleukin 17A Sales Market Share by Application in 2022 & 2034
Figure 38. North America Interleukin 17A Sales Market Share in Volume by Application in 2022
Figure 39. North America Interleukin 17A Sales Market Share in Value by Application in 2022
Figure 40. Europe Interleukin 17A Sales Market Share in Volume by Application in 2022
Figure 41. Europe Interleukin 17A Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Interleukin 17A Sales Market Share in Value by Application in 2022
Figure 44. Latin America Interleukin 17A Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Interleukin 17A Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Interleukin 17A Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Interleukin 17A Manufacturing Cost Structure
Figure 49. Interleukin 17A Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries